Patterns and clinical outcomes of antidepressant prescribing in children and adolescents: real-world evidence from a mental health hospital in Türkiye
Muster und klinische Ergebnisse der Verordnung von Antidepressiva bei Kindern und Jugendlichen: Real-World-Evidenz aus einem psychiatrischen Krankenhaus in Türkiye
Frontiers in Psychiatry · 29.10.2026 · 17
DOI: 10.3389/fpsyt.2026.1947706 ↗Auf einen Blick
Bei 650 Patient:innen im Alter von 4–17 Jahren waren SSRIs am häufigsten verordnet; 84,6 % zeigten eine positive CGI-I-Antwort. Häufige Nebenwirkungen waren Sedierung und Gewichtszunahme.
Fragestellung
Welche Verordnungsmuster, klinischen Ergebnisse, Off-label-Verordnungen und Nebenwirkungen sind bei Kindern und Jugendlichen unter Antidepressiva mit Faktoren verbunden?
Methode
Einzentrische retrospektive Auswertung von 650 Patient:innen im öffentlichen psychiatrischen Krankenhaus zwischen August 2020 und Dezember 2021; multivariable logistische Regression.
Ergebnisse
92,5 % erhielten mindestens ein SSRI, vor allem Fluoxetin (48,2 %) und Sertralin (34,2 %). Off-label erfolgte die Verordnung bei 74,8 %, 43,8 % erhielten Begleitmedikation. Unerwünschte Wirkungen traten bei 21,4 % auf.
Einschränkungen
Einzentrige retrospektive Studie ohne Kontrollgruppe; die Autoren betonen, dass die positive CGI-I-Antwort keine Wirksamkeit belegt.
Schlussfolgerung der Autor:innen
In dieser Einzelsample-Studie waren Antidepressiva vor allem bei weiblichen Patient:innen und älteren Jugendlichen verordnet, meist als SSRI und häufig Off-label. Jüngeres Alter war mit besserer klinischer Verbesserung verbunden.
Kernaussagen
- SSRIs dominierten die Verordnung bei 650 Patient:innen
- Off-label-Verordnung bei 74,8 %
- Begleitbehandlung war mit mehr Nebenwirkungen verbunden
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 29.10.2026. Verfasst von Asiye Arıcı Gürbüz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Adana Dr. Ekrem Tok Mental Health Hospital, Adana, Türkiye. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Antidepressant use in child and adolescent psychiatry has increased diagnoses, antidepressant data from Türkiye remain scarce. This study aimed to describe antidepressant prescribing patterns and to explore clinical and demographic factors associated with clinical improvement, off-label use and adverse effects in a child and adolescent psychiatry outpatient population.
Methods
This single-centre retrospective study reviewed the records of 650 patients aged 4–17 years prescribed antidepressants at a public mental health hospital between August 2020 and December 2021.Demographic characteristics, psychiatric diagnoses, antidepressant agents and doses, off-label status (FDA paediatric labelling),concomitant psychotropic treatment, adverse effects and Clinical Global Impression (CGI) ratings were extracted. A positive response was defined as a CGI-Improvement (CGI-I) score of 1–2 at the last recorded follow-up. Multivariable logistic regression was used to explore factors associated with CGI-I response, off-label prescribing and adverse effects.
Results
Most patients were female (58.9%), and 43.8% were aged 15–17 years; the mean age was 13.23 ± 3.18 years. At least one selective serotonin reuptake inhibitor (SSRI) was prescribed to 92.5% of patients, mainly fluoxetine (48.2%) and sertraline (34.2%).Anxiety disorders (41.8%),major depressive disorder (MDD; 37.8%) and attention-deficit/hyperactivity disorder (ADHD;28.8%) were the most frequent diagnoses. Prescribing was off-label in 74.8%, and 43.8% received concomitant psychotropic treatment. Adverse effects, mainly sedation and weight gain, occurred in 21.4% (monotherapy 11.8% vs. concomitant treatment 33.7%).A positive CGI-I response was recorded in 84.6%;without a control group, this does not indicate efficacy. Relative to age 4–10 years, age 11–14 years (aOR 0.37,95%CI 0.17–0.83) and 15–17 years (aOR 0.28,95% CI 0.13–0.61), and a prior antidepressant trial (aOR 0.46,95%CI 0.27–0.78),were associated with lower odds of a positive response. Off-label prescribing was more likely in generalised anxiety disorder (aOR 2.41,95%CI 1.35–4.30) and less likely in MDD (aOR 0.31,95% CI 0.21–0.47).Adverse effects were associated with concomitant treatment (aOR 3.32,95% CI 2.14–5.16) and ADHD (aOR 1.77,95%CI 1.17–2.69).
Conclusions
In this single-centre sample, antidepressant prescribing was most common among female patients and older adolescents, dominated by SSRIs, frequently off-label and often combined with other psychotropics. Younger age was associated with greater clinical improvement, and concomitant treatment with adverse effects. These exploratory, non-causal findings highlight the need for prospective, multicentre studies with standardised outcome assessment to inform prescribing guidelines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Child and Adolescent Psychiatry, Adana Dr. Ekrem Tok Mental Health Hospital, Adana, Türkiye.
- Department of Child and Adolescent Psychiatry, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Türkiye.
Zitieren
APA
Arıcı Gürbüz, A., & Altun, H. (2026). Patterns and clinical outcomes of antidepressant prescribing in children and adolescents: real-world evidence from a mental health hospital in Türkiye. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1947706
Vancouver
Arıcı Gürbüz A, Altun H. Patterns and clinical outcomes of antidepressant prescribing in children and adolescents: real-world evidence from a mental health hospital in Türkiye. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1947706
BibTeX
@article{ArcGrbz2026,
author = {Arıcı Gürbüz, Asiye and Altun, Hatice},
title = {Patterns and clinical outcomes of antidepressant prescribing in children and adolescents: real-world evidence from a mental health hospital in Türkiye},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1947706}
}
EUVIMED